Strategic Focus Target the Kansas Bioscience Authority as a potential partner or funder for early-stage bioscience ventures, especially in agribusiness, animal health, and human health, given their focus on disruptive technologies and portfolio management to accelerate exits.

Funding and Partnerships Leverage KBA’s model of investing their own funds alongside co-investors and their network of experts to explore co-investment opportunities, strategic partnerships, and potential deal-sourcing collaborations for portfolio companies in biotech.

Market Position Position offerings around accelerating commercialization, with emphasis on short-exit opportunities in human health and animal health segments, aligning with KBA’s track record of funding rounds, commercialization, IPOs or sales.

Regional Access Highlight Kansas as a gateway for agribusiness and bioscience innovation, offering regional advantages, local collaboration opportunities, and potential government-acted incentives that may interest KBA and its portfolio companies.

Smaller Team, Big Impact Speak to KBA’s lean team size and self-sustaining venture model as a reason to engage with flexible, value-driven solutions, including rapid diligence, nimble co-funding structures, and scalable partnerships for portfolio growth.